These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22469857)

  • 1. The effect of the NF-kappa B inhibitors curcumin and lactacystin on myogenic differentiation of rhabdomyosarcoma cells.
    Berger F; Büchsler I; Munz B
    Differentiation; 2012 Jun; 83(5):271-81. PubMed ID: 22469857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways.
    Liao S; Xia J; Chen Z; Zhang S; Ahmad A; Miele L; Sarkar FH; Wang Z
    J Cell Biochem; 2011 Apr; 112(4):1055-65. PubMed ID: 21308734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
    Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
    FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
    Tubaro C; Arcuri C; Giambanco I; Donato R
    J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
    Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
    Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway].
    Tian F; Song M; Xu PR; Liu HT; Xue LX
    Ai Zheng; 2008 Jun; 27(6):566-70. PubMed ID: 18570726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
    Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
    Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
    Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
    Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
    Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma.
    Al-Tahan A; Sarkis O; Harajly M; Baghdadi OK; Zibara K; Boulos F; Dighe D; Kregel S; Bazarbachi A; El-Sabban M; Skapek SX; Saab R
    Pediatr Blood Cancer; 2012 Jun; 58(6):877-84. PubMed ID: 21755593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of angular naphthopyrones from the Philippine echinoderm Comanthus species as inhibitors of the NF-κB signaling pathway.
    Chovolou Y; Ebada SS; Wätjen W; Proksch P
    Eur J Pharmacol; 2011 Apr; 657(1-3):26-34. PubMed ID: 21296074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
    Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical assessment of curcumin as a potential therapy for B-CLL.
    Everett PC; Meyers JA; Makkinje A; Rabbi M; Lerner A
    Am J Hematol; 2007 Jan; 82(1):23-30. PubMed ID: 16947318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
    Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
    Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.